Article
A novel 4‐mRNA signature predicts the overall survival in acute myeloid leukemia
2 Aug 2021
Abstract excerpt
Acute myeloid leukemia (AML) is an aggressive cancer of myeloid cells with high levels of heterogeneity and great variability in prognostic behaviors. Cytogenetic abnormalities and genetic mutations have been widely used in the prognostic stratification of AML to assign patients into different risk categories. Nevertheless, nearly half of AML patients assigned to intermediate risk need more precise prognostic...
Topics
Join the communities discussing this publication.
